Opioid-Related Disorders
Conditions
Keywords
HIV, methadone maintenance
Brief summary
The purpose of this study is to evaluate HIV counseling intervention for Methadone-Maintained Patients.
Detailed description
The purpose of this proposal is to evaluate, in methadone-maintained patients the association between an ADHD diagnosis and high-risk HIV/Hepatitis behavior. In addition, the investigators would like to determine whether a new manually-guided HIV intervention; RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounters is superior to standard HIV/Hepatitis psycho-education.
Interventions
BEHAVIORALBehavior Therapy-RISE
manually-guided HIV intervention RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounter
BEHAVIORALStandard prevention Education
standard psychosocial Education for HIV/hepatitis prevention
Sponsors
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Must meet DSM-IV criteria for opiate dependence and currently in methadone maintenance treatment * Able to give informed consent and capable of complying with study procedures * Women who are of childbearing age and/or pregnant may be included * Individuals who are HIV-positive or have Acquired Immunodeficiency Syndrome may be included * Patients who demonstrate moderate to high HIV risk behaviors will be included * Patients with low to no HIV risk behaviors will be excluded * Patients receiving a stable dose of methadone for three weeks will be included
Exclusion criteria
* Currently meets DSM-IV criteria for current Axis I psychiatric disorders (other than ADHD or substance abuse) which requires medical intervention, i.e., active suicide ideation, active psychosis, anxiety disorders, depression requiring hospitalization * Patients who have exhibited suicidal or homicidal behavior within the past two years * HIV positive patients must have knowledge of their status for a minimum of three weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AIDS risk behavior based on the Risk Behavior Assessment | assessed monthly during 2 months of study or length of participation |
Countries
United States
Outcome results
None listed